<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Vestibular migraine</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Vestibular migraine</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Vestibular migraine</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Elizabeth Robertson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott DZ Eggers, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jerry W Swanson, MD, MHPE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Vestibular migraine is a syndrome characterized by recurrent episodes of vertigo or other vestibular symptoms attributed to migraine.</p><p>This topic will review the clinical features, diagnosis, and management of vestibular migraine. Other aspects of migraine are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3347.html" rel="external">"Acute treatment of migraine in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3345.html" rel="external">"Preventive treatment of episodic migraine in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6168.html" rel="external">"Acute treatment of migraine in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/98355.html" rel="external">"Preventive treatment of migraine in children"</a>.)</p><p></p><p>Migraine with brainstem aura is a related condition featuring a complex aura that may include vertigo along with other brainstem symptoms and is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3352.html" rel="external">"Migraine with brainstem aura"</a>.)</p><p>Other causes of vertigo are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">"Causes of vertigo"</a>.)</p><p class="headingAnchor" id="H2306496957"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Vestibular migraine was previously identified by other terms including migraine-associated vertigo, migraine-associated dizziness, migraine-related vestibulopathy, and migrainous vertigo [<a href="#rid1">1,2</a>].</p><p>Childhood precursors to migraine and vestibular migraine in adulthood include vestibular migraine of childhood, benign paroxysmal vertigo of childhood, and recurrent vertigo of childhood [<a href="#rid2">2-5</a>]. (See  <a class="medical medical_review" href="/z/d/html/6202.html" rel="external">"Types of migraine and related syndromes in children", section on 'Recurrent vestibular symptoms'</a>.)</p><p>Vestibular migraine is considered to be distinct from migraine with brainstem aura, previously known as basilar migraine [<a href="#rid2">2,6,7</a>]. (See  <a class="medical medical_review" href="/z/d/html/3352.html" rel="external">"Migraine with brainstem aura"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">PATHOPHYSIOLOGY AND DISEASE ASSOCIATIONS</span><span class="headingEndMark"> — </span>The pathophysiology of vestibular migraine is incompletely understood. The wide spectrum of clinical and laboratory features of vestibular dysfunction that overlap with migraine and other vestibular disorders suggests a heterogeneous pathophysiology [<a href="#rid8">8-10</a>]. Several factors have hindered the study of vestibular migraine including the lack of biologic markers or specific tests, lack of standard nomenclature, and evolving consensus diagnostic criteria. Several potential mechanisms are proposed; these are not mutually exclusive.</p><p class="headingAnchor" id="H2528055657"><span class="h2">Vestibular dysfunction and migraine</span><span class="headingEndMark"> — </span>An association between episodic vertigo and migraine was noted as early as 1873 [<a href="#rid11">11</a>]. A contemporary association between vertigo and migraine has been noted by observational studies reporting a high prevalence of vestibular symptoms in patients with migraine and other studies identifying a high prevalence of migraine in patients with episodic vestibular symptoms.</p><p>Among patients with migraine, a history of episodic vertigo is reported by 20 to 33 percent [<a href="#rid8">8,12-15</a>]. This contrasts with studies reporting the prevalence of vertigo for patients with tension-type headaches and the lifetime prevalence of vertigo in the general population, both estimated at generally less than 8 percent [<a href="#rid8">8,16,17</a>]. One-half to two-thirds of migraineurs also report motion sickness [<a href="#rid8">8,12,18-21</a>]. This prevalence is probably two to five times greater than in the general population. Patients with migraine also appear more susceptible to visually induced motion sickness and have more severe symptoms [<a href="#rid22">22,23</a>]. (See  <a class="medical medical_review" href="/z/d/html/6853.html" rel="external">"Motion sickness"</a>.)</p><p>Nonlocalizing vestibular signs and signs suggestive of central vestibular dysfunction are common but also quite variable among studies of patients with migraine. Mild interictal vestibular and oculomotor signs (spontaneous, positional, or gaze-evoked nystagmus; abnormal vestibulo-ocular reflex; impaired ocular pursuit) have been reported in 20 to 66 percent of patients with migraine [<a href="#rid6">6,12,24-28</a>].</p><p>Among patients with episodic vertigo, the prevalence of migraine has been estimated between 38 and 87 percent [<a href="#rid29">29-31</a>]. In one study, family members of patients with vertigo also had a higher-than-expected prevalence of migraine [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H87666129"><span class="h3">Pathogenesis</span><span class="headingEndMark"> — </span>Several hypotheses have been proposed that describe the onset of vestibular migraine symptoms as a component of episodic migraine.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Precursor to migraine</strong> – Vestibular migraine may be a precursor to more typical forms of migraine in adults, similar to the relationship between benign paroxysmal vertigo of childhood and migraine in the pediatric population [<a href="#rid33">33-35</a>]. Long-term follow-up of children with benign paroxysmal vertigo suggests that most will go on to develop migraine later in life [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/z/d/html/6202.html" rel="external">"Types of migraine and related syndromes in children", section on 'Benign paroxysmal vertigo of childhood'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Migraine aura</strong> – For some patients, vestibular migraine may represent a typical migraine aura. Patients may report transient vestibular symptoms, sometimes accompanied by visual or other neurologic symptoms and followed by onset of a migraine headache. However, this sequence occurs only in a minority of patients. In case series, only 2 to 30 percent of patients with vestibular migraine had vestibular symptoms meeting this description [<a href="#rid6">6,7,29,36,37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Migraine trigger</strong> – Episodic vertigo may act as a migraine trigger. Evidence for this is limited but includes a report of three individuals who had migraine attacks shortly after caloric testing [<a href="#rid38">38</a>]. In another observational study based in a neurotology clinic, nearly half of migraine patients who underwent vestibular testing experienced a migraine within 24 hours of testing, compared with 12 percent of patients without a migraine history and 5 percent among those who did not receive vestibular testing [<a href="#rid39">39</a>].</p><p></p><p class="headingAnchor" id="H483985339"><span class="h3">Migrainous mechanisms</span><span class="headingEndMark"> — </span>Pathophysiologic processes that account for migraine include vestibulocerebellar pathways that may be preferentially implicated in patients with vestibular migraine.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trigeminovascular system</strong> – Trigeminal ganglion excitation and release of vasoactive neuropeptides such as substance P, pituitary adenylate-cyclase-activating polypeptide, and calcitonin gene-related peptide (CGRP) are thought to contribute to the headache pain of migraine. Vestibular symptoms may also be attributed to trigeminovascular activation [<a href="#rid37">37</a>]. The presence of receptors to vasoactive neuropeptides and heightened immunoreactivity have been shown to alter function in vestibular nuclei [<a href="#rid40">40,41</a>]. Activation of central vestibular nuclei can also alter monoaminergic activation that in turn modulates migrainous symptoms and pain pathways [<a href="#rid25">25</a>]. In addition, transcutaneous electrical stimulation of the trigeminal nerve has been shown to produce nystagmus in patients with migraine [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Trigeminovascular system'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spreading depression</strong> – Cortical spreading depression describes a wave of neuronal and glial depolarizations that may account for the migraine aura by activating trigeminal afferent pathways. Vestibular migraine has been hypothesized to be a "brainstem aura" in the vestibular nuclei due either to noncortical spreading depression or to cortical spreading depression via direct projections from the posterior parietal cortex [<a href="#rid6">6,25</a>]. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Cortical spreading depression'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sensory sensitivity</strong> – Neuronal sensitization involves a progressive increased responsiveness to peripheral stimulation leading to migraine by a reduction of response thresholds, increased magnitude of response, and spontaneous neuronal activity. This process may account for the sensitivities many patients with migraine report including motion, lights, sound, tactile stimuli, and smells. In addition, these patients may be more likely to exhibit motion sickness or other subclinical vestibulocerebellar abnormalities [<a href="#rid23">23,25,43-46</a>]. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Sensitization'</a>.)</p><p></p><p class="bulletIndent1">Some experts believe vestibular migraine is related to both central sensitization and aberrant sensory integration in vestibulo-thalamo-cortical processing because multisensory integration occurs at the level of the thalamus and the cortex [<a href="#rid47">47</a>]. Functional imaging studies have shown altered functional connectivity between the thalamus and brain regions involved in visual and vestibular processing and pain [<a href="#rid48">48</a>]. In one study, cortical structural abnormalities and resting state functional connectivity abnormalities were found in areas of the temporal and parietal lobes, areas that participate in multisensory integration [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Channelopathies</strong> – Vestibular symptoms may arise from an inherited channelopathy for some patients with migraine [<a href="#rid18">18</a>]. One channelopathy, episodic ataxia type 2 (EA2), manifests clinically with episodic vertigo. Half of patients with this disorder have migraine [<a href="#rid50">50,51</a>]. Another disorder, familial hemiplegic migraine (FHM), is associated with a genetic abnormality of the same calcium channel [<a href="#rid52">52</a>]. Both of these disorders have been linked to a genetic variant on chromosome 19p. (See  <a class="medical medical_review" href="/z/d/html/6234.html" rel="external">"Overview of the hereditary ataxias", section on 'Episodic ataxias'</a> and  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Familial hemiplegic migraine'</a>.)</p><p></p><p class="bulletIndent1">Kindreds with apparently dominantly inherited syndromes that include both migraine and episodic vertigo have also been described [<a href="#rid53">53-55</a>]. While a similar ion channel genetic defect is suspected, a gene locus in these families is not yet identified; linkage analysis ruled out a linkage to the 19p locus associated with EA2 and FHM.</p><p></p><p class="headingAnchor" id="H4049700339"><span class="h2">Other sources of vestibular dysfunction</span><span class="headingEndMark"> — </span>Nonmigrainous mechanisms have also been proposed to account for symptoms of vestibular migraine.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ischemic damage</strong> – Migraine-induced ischemia of the inner ear may lead to cochlear and labyrinth injury, altering the excitability of these structures [<a href="#rid56">56,57</a>]. Migraine appears to be a risk factor for ischemic stroke, perhaps related to vasospasm. However, given the duration and recurrence of these symptoms and the absence of evidence of ischemia, vestibulocochlear ischemia is an unlikely explanation for most cases of vestibular migraine.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Endolymphatic hydrops</strong> – Endolymphatic hydrops, a distention of the membranous, endolymph-containing portions of the labyrinthine system, is the pathologic lesion underlying Meniere disease. Some experts suggest that vestibular migraine and Meniere disease are associated, while others suggest that the overlap in presentation may lead to misdiagnosis [<a href="#rid58">58,59</a>]. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/6859.html" rel="external">"Meniere disease: Evaluation, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1">The attacks of vertigo that characterize Meniere disease and migraine are frequently similar in duration. One study observed that attacks of vertigo in patients with Meniere disease have migrainous features (headache, photophobia, or visual aura) in 45 percent of patients [<a href="#rid56">56</a>]. This study also reported that patients with Meniere disease had an increased lifetime prevalence of migraine compared with controls (56 versus 25 percent). In another study, approximately one-quarter of patients with either condition met criteria for both diagnoses [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1">A channelopathy causing migraine could also cause an osmotic disequilibrium in the inner ear, resulting in endolymphatic hydrops [<a href="#rid56">56</a>]. Alternatively, migraine-associated ischemia could damage the labyrinth and produce endolymphatic hydrops on that basis [<a href="#rid57">57</a>].</p><p></p><p class="headingAnchor" id="H193359614"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Vestibular migraine is considered to be a common vestibular disorder, but its prevalence is not known. A population-based study in Germany estimated a lifetime prevalence of vestibular migraine of approximately 1 percent [<a href="#rid36">36</a>], while a survey in the United States found a one-year prevalence of 2.7 percent [<a href="#rid60">60</a>]. Other epidemiology studies have used different diagnostic criteria but reported similar results [<a href="#rid24">24,61</a>]. However, epidemiologic studies may be limited by several factors including case misattribution, evolving diagnostic criteria, and referral biases [<a href="#rid59">59</a>]. Vestibular migraine may account for up to 30 percent of patients seeking treatment for episodic dizziness [<a href="#rid62">62</a>]. While two-thirds of patients identified as having vestibular migraine had consulted a clinician regarding this problem, only 20 percent were given that diagnosis [<a href="#rid60">60</a>].</p><p>Vestibular migraine is more common among females (60 to 83 percent) than males [<a href="#rid6">6,12,29,36,37,63</a>]. This sex ratio is similar to that reported in migraine. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Epidemiology'</a>.)</p><p>Vestibular migraine may be diagnosed more frequently in children than adults [<a href="#rid25">25</a>]. In adult case series, the mean age of onset of vertigo in migraine is approximately 40 years old [<a href="#rid6">6,12,36</a>]. However, in one series, a first attack occurred in a patient who was 72 years old [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H4157007658"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Vestibular migraine is characterized by recurrent episodes of transient vertigo. Most patients also have migraine-type headaches.</p><p>A history of migraine headaches (without vestibular symptoms) typically precedes the development of vestibular migraine, often by several years [<a href="#rid64">64</a>]. However, in some patients, episodes of vertigo precede onset of migraine headaches, such as those with paroxysmal vertigo of childhood who later develop migraine headaches with features consistent with vestibular migraine. Sometimes headache episodes are replaced by vertigo episodes in later life, such as around menopause.</p><p>Evolving diagnostic criteria that require migrainous history or features may also influence understanding of these clinical presentations [<a href="#rid29">29,36,65</a>]. (See <a class="local">'Diagnostic criteria'</a> below.)</p><p class="headingAnchor" id="H3686066957"><span class="h2">Clinical symptoms</span></p><p class="headingAnchor" id="H487070334"><span class="h3">Episodic vertigo</span><span class="headingEndMark"> — </span>The vestibular symptoms that characterize episodes of vestibular migraine can be perceived as internal vertigo (a false sensation of self-motion) or external vertigo (a false sensation that the visual surround is spinning or flowing). The character of the vertigo is often rotational but can also be rocking, swaying, tilting, falling, or floating [<a href="#rid6">6,66</a>].</p><p>Other commonly described vestibular symptoms include unsteadiness, visually induced vertigo (provoked by complex or large moving visual scenes, such as traffic or moving trains), head motion intolerance (a sense of motion and nausea provoked or aggravated by head movement), and nonvertiginous "dizzy" symptoms such as lightheadedness [<a href="#rid12">12,67-69</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Duration</strong> – The duration of an episode of vestibular migraine is variable but typically last minutes to several hours. However, symptoms may last only a few minutes for some patients (&lt;15 percent) and more than 24 hours for others (up to 25 percent) [<a href="#rid2">2,6,12,25,29,36,37,63,67,70</a>].</p><p></p><p class="bulletIndent1">Following the resolution of an acute episode, most patients have motion intolerance and unsteadiness for a day or more. It is rare for symptoms to persist for more than 72 hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frequency</strong> – The typical frequency of attacks varies from daily to one or two each month [<a href="#rid6">6,12,37,71</a>]. However, episodes may occur several times each day or on a near constant basis for some patients [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Triggers</strong> – Vestibular migraine episodes are often spontaneous. However, they may also be triggered by environmental stimuli similar to patients with other forms of migraine [<a href="#rid24">24,72</a>]. These triggers include [<a href="#rid68">68,70,73,74</a>] (see  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Precipitating and exacerbating factors'</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sleep deprivation</p><p class="bulletIndent2"><span class="glyph">•</span>Stress</p><p class="bulletIndent2"><span class="glyph">•</span>Certain foods</p><p class="bulletIndent2"><span class="glyph">•</span>Visual stimuli (eg, fluorescent lights, moving trains, crowds, busy visual patterns)</p><p class="bulletIndent2"><span class="glyph">•</span>Change of head position</p><p></p><p class="bulletIndent1">Symptoms that are triggered by specific head positions typically persist as long as the precipitating head position is maintained or until the episode resolves, in contrast to patients with benign paroxysmal positional vertigo who typically report improvement of symptoms after head movement ceases. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="headingAnchor" id="H1645311443"><span class="h3">Migraine headache</span><span class="headingEndMark"> — </span>While vestibular migraine episodes may occur either with or without headache, migrainous headaches are associated with at least some of the vestibular episodes in 50 to 94 percent of patients [<a href="#rid12">12,29,36,63,66,70,71,73</a>]. However, it is uncommon for patients with vestibular migraine to report a consistent temporal relationship between the vertigo and headache [<a href="#rid12">12,37,75</a>]. The vertigo may occur prior to or during a migraine headache. Few patients experience vertigo consistently as a typical aura immediately prior to headache onset [<a href="#rid7">7,36</a>].</p><p class="headingAnchor" id="H985358590"><span class="h3">Other ictal features</span><span class="headingEndMark"> — </span>Additional migrainous symptoms other than headache (photophobia, phonophobia, visual aura) often occur during the episodes of vertigo [<a href="#rid12">12,29,36,70</a>]. Sensitivity to sound, or phonophobia, occurs in two-thirds of patients [<a href="#rid18">18</a>]. However, visual and other auras are uncommon [<a href="#rid7">7,36</a>].</p><p>Auditory symptoms such as bilateral or unilateral tinnitus, aural fullness, or subjective hearing impairment are relatively common during vestibular migraine attacks. However, transient auditory symptoms are typically mild, unlike some patients with Meniere disease with more severe or persisting symptoms [<a href="#rid8">8,12,15,18,36,58,71</a>]. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Nausea and vomiting are frequent, but nonspecific, and may be attributed to vertigo of any cause. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H195586703"><span class="h2">Interictal symptoms</span><span class="headingEndMark"> — </span>Although vestibular migraine is considered an episodic vestibular disorder, many patients report a high prevalence of mild vestibular symptoms between attacks. There is controversy surrounding whether these interictal vestibular symptoms should be considered chronic vestibular migraine or a comorbid vestibular disorder such as persistent postural-perceptual dizziness (PPPD) [<a href="#rid7">7,66,76,77</a>]. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Patients with vestibular migraine frequently report visually induced and head motion-induced dizziness even when such stimuli do not trigger a full episode of vestibular migraine [<a href="#rid78">78</a>]. A susceptibility to motion sickness may be more prominent in patients with vestibular migraine rather than other forms of migraine [<a href="#rid21">21,78,79</a>]. (See  <a class="medical medical_review" href="/z/d/html/6853.html" rel="external">"Motion sickness", section on 'Patient factors'</a>.)</p><p>Patients with vestibular migraine have higher rates of anxiety and depression compared with controls or those with other vestibular disorders [<a href="#rid66">66,80-83</a>]. Anxiety may be a consequence of unpredictable, disabling symptoms and may also exacerbate symptoms during acute episodes [<a href="#rid24">24,73</a>].</p><p class="headingAnchor" id="H307359022"><span class="h2">Examination findings</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nystagmus</strong> – Nystagmus is typically present during an episode of vestibular migraine. Features may be suggestive of either peripheral or central origin  (<a class="graphic graphic_table graphicRef76359" href="/z/d/graphic/76359.html" rel="external">table 1</a>); they may be spontaneous, gaze-evoked, or solely positional. Nystagmus can be identified during routine neurologic examination with tools to block visual fixation such as occlusive ophthalmoscopy, the penlight-cover test, Frenzel lenses, or video oculography [<a href="#rid24">24,84-87</a>]. (See  <a class="medical medical_review" href="/z/d/html/5094.html" rel="external">"Evaluation of the patient with vertigo", section on 'Nystagmus'</a>.) </p><p></p><p class="bulletIndent1">Spontaneous horizontal nystagmus is common during vestibular migraine episodes, but intense spontaneous horizontal nystagmus is more suggestive of Meniere disease; vertical nystagmus is more typical with vestibular migraine [<a href="#rid88">88</a>]. Interictal nystagmus is uncommon in vestibular migraine. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1">During the symptom-free period between episodes, the bedside vestibular and oculomotor examination is generally normal. However, patients may exhibit very low-velocity spontaneous or positional nystagmus when examined with vision denied [<a href="#rid85">85</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other examination findings</strong> – Impaired smooth pursuit may be seen on extraocular muscle examination and abnormalities of the vestibulo-ocular reflex may be seen during episodes by video head impulse testing  (<a class="graphic graphic_figure graphicRef52022" href="/z/d/graphic/52022.html" rel="external">figure 1</a>). Interictal testing usually reveals a normal symmetric vestibulo-ocular reflex, although these and other vestibular laboratory tests such as vestibular-evoked myogenic potentials reveal nonspecific abnormalities in a small minority of patients with vestibular migraine [<a href="#rid10">10,37,85</a>]. (See  <a class="medical medical_review" href="/z/d/html/5094.html" rel="external">"Evaluation of the patient with vertigo", section on 'Head impulse test'</a>.)</p><p></p><p class="bulletIndent1">Most patients have impaired gait and stance on examination during episodes.</p><p></p><p class="headingAnchor" id="H1377205062"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of vestibular migraine should be considered in patients with recurrent episodes of vertigo associated with a history of migraine headaches. The diagnosis of vestibular migraine is made clinically in patients who fulfill diagnostic criteria, after excluding alternative causes of episodic vestibular symptoms.</p><p class="headingAnchor" id="H2513180344"><span class="h2">Diagnostic criteria</span><span class="headingEndMark"> — </span>Clinical criteria have been jointly developed by the Bárány Society and the International Classification of Headache Disorders (ICHD-3) [<a href="#rid2">2,89</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>At least five episodes of vestibular symptoms of moderate or severe intensity, lasting between 5 minutes and 72 hours</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One or more migrainous feature with at least 50 percent of vestibular episodes, including:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Headache with at least two of the following characteristics (unilateral, pulsating, moderate or severe intensity, aggravation by routine physical activity)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Photophobia and phonophobia</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Visual aura</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A current or past history of migraine (with or without aura)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms not better accounted for by another diagnosis</p><p></p><p>Qualifying vestibular symptoms include spontaneous vertigo, positional vertigo, visually induced vertigo, head-motion-induced vertigo, or head-motion-induced nonvertiginous dizziness with nausea. Vestibular symptoms are considered moderate to severe if they interfere with daily activities.</p><p>The Bárány Society also developed criteria for probable vestibular migraine that can be applied when the patient has either migrainous features during the vestibular episodes or a current or past history of migraine, but not both [<a href="#rid1">1</a>]. For these patients, we perform diagnostic testing to evaluate for alternative causes of symptoms and reassess the diagnosis if the patient does not respond to treatment or if the clinical features change. In one study, 75 patients diagnosed with vestibular migraine according to similar criteria were reassessed after a mean of nine years [<a href="#rid70">70</a>]. More than 80 percent of patients continued to be considered as having probable or definite vestibular migraine, while the diagnosis was revised in 12 patients, most often to Meniere disease.</p><p class="headingAnchor" id="H3829769140"><span class="h2">Evaluation to exclude alternative conditions</span></p><p class="headingAnchor" id="H1416975840"><span class="h3">Indications for diagnostic testing</span><span class="headingEndMark"> — </span>There are no conclusive diagnostic tests for migraine or vestibular migraine. We perform diagnostic testing to exclude alternative causes of episodic vertigo for patients with new-onset symptoms that do not fulfill diagnostic criteria. In addition, diagnostic testing is warranted for those with atypical clinical features including any of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Vestibular symptoms that are either very brief (eg, seconds up to a few minutes) or prolonged (eg, &gt;72 hours)</p><p class="bulletIndent1"><span class="glyph">●</span>Sudden, fluctuating, or progressive hearing loss or other auditory symptoms </p><p class="bulletIndent1"><span class="glyph">●</span>Loss of consciousness during episode</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic signs on general examination (eg, fever, rash)</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal signs on neurologic examination (eg, limb weakness, cranial nerve palsies)</p><p></p><p>Diagnostic testing may be <strong>unnecessary</strong> for patients with a longstanding history of episodic vertigo meeting diagnostic criteria for vestibular migraine, no atypical features to suggest an alternative diagnosis, and a normal examination between episodes.</p><p class="headingAnchor" id="H2090263993"><span class="h3">Neuroimaging</span><span class="headingEndMark"> — </span>We suggest neuroimaging to evaluate for transient ischemic attack (TIA) or stroke when acute vestibular episodes are either new onset, associated with other abnormal neurologic findings on examination, or occur in patients with risk factors for stroke. Noncontrast computed tomography (CT) of the head is often performed as an initial imaging study for patients with acute stroke symptoms including those with isolated vertigo because it is typically easier to perform quickly, but it has poor sensitivity for detecting acute ischemia in the posterior fossa. Magnetic resonance imaging (MRI) of the brain without contrast with diffusion-weighted sequences is more sensitive for detecting acute ischemia. Vascular imaging with CT or MR angiography of the head and neck is performed to identify vascular stenoses or occlusion as a cause of symptoms.</p><p>Brain MRI with contrast including high-resolution 3D protocols that include submillimeter slices through the internal auditory canal should be performed for patients with acute persisting or chronic vestibular symptoms to evaluate for structural causes to symptoms such as tumors of the posterior fossa.</p><p class="headingAnchor" id="H2739269371"><span class="h3">Audiometry</span><span class="headingEndMark"> — </span>We suggest audiometry for patients with prominent or monaural auditory symptoms during episodes and those with symptoms that persist after episodes resolve to assess for features of Meniere disease or superior semicircular canal dehiscence syndrome. A follow-up audiometry study can be helpful when an initial study is negative and the diagnosis remains unclear [<a href="#rid70">70</a>]. (See  <a class="medical medical_review" href="/z/d/html/6859.html" rel="external">"Meniere disease: Evaluation, diagnosis, and management"</a> and  <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">"Causes of vertigo", section on 'Semicircular canal dehiscence syndrome'</a>.)</p><p class="headingAnchor" id="H2440089649"><span class="h3">Other testing for patients with atypical symptoms</span></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with very brief attacks of vertigo that are positionally induced should be evaluated clinically for benign paroxysmal positional vertigo (BPPV). (See  <a class="medical medical_review" href="/z/d/html/5098.html" rel="external">"Benign paroxysmal positional vertigo"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vestibular laboratory testing is not typically required for the diagnosis of vestibular migraine and frequently reveals nonspecific abnormalities in patients with vestibular migraine [<a href="#rid10">10,37,85</a>]. Testing can be helpful in selected patients for identifying significant peripheral or central vestibular dysfunction from an alternative diagnosis.</p><p></p><p>For patients with symptoms atypical for vestibular migraine, and for patients who do not respond adequately to treatment for vestibular migraine, it is appropriate to broaden the extent of testing to evaluate alternative or comorbid conditions. The evaluation of a patient with vertigo is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/5094.html" rel="external">"Evaluation of the patient with vertigo"</a>.)</p><p class="headingAnchor" id="H2482649263"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>There are many causes of vertigo, but common causes of episodic vertigo can be distinguished by the duration of attacks and the presence of associated symptoms  (<a class="graphic graphic_table graphicRef81596" href="/z/d/graphic/81596.html" rel="external">table 2</a>). The major considerations in the differential diagnosis of vestibular migraine are those disorders that produce vertigo with a similar tempo and duration of symptoms. These most often include Meniere disease, other migraine variants, and vertebrobasilar transient ischemic attacks (TIAs).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Meniere disease</strong> – Symptoms associated with Meniere disease include recurrent episodes of vertigo, unilateral tinnitus, and unilateral hearing loss. These symptoms can also occur in patients with vestibular migraine, making it difficult to distinguish these conditions [<a href="#rid56">56,58</a>]. In addition, some typically migrainous symptoms, including headache, are common in attacks of Meniere disease [<a href="#rid2">2,56,76</a>]. The clinical presentation of Meniere disease may also be variable. In rare patients with Meniere disease, vestibular symptoms predominate and audiologic symptoms may be minor or absent [<a href="#rid36">36,56,58,90</a>]. (See  <a class="medical medical_review" href="/z/d/html/6859.html" rel="external">"Meniere disease: Evaluation, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1">However, Meniere disease is approximately one-tenth as common as vestibular migraine in population studies [<a href="#rid36">36</a>]. Patients with Meniere disease frequently report transient ear fullness preceding the attack or at attack onset. Fluctuating and progressive hearing loss and other monaural symptoms are common in Meniere disease; various auditory symptoms have also been described in vestibular migraine, but they are typically transient. Audiometry examinations showing progressive or fluctuating low- to medium-frequency hearing loss are most useful in identifying the condition as Meniere disease [<a href="#rid70">70</a>]. Nystagmus occurs during both Meniere disease and vestibular migraine attacks, but very intense spontaneous horizontal nystagmus (&gt;12 degrees per second) may suggest a diagnosis of Meniere disease over vestibular migraine [<a href="#rid88">88</a>].</p><p></p><p class="bulletIndent1">Meniere disease and migraine can be comorbid [<a href="#rid76">76</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Migraine with brainstem aura</strong> – Migraine with brainstem aura (MBA) is a form of migraine with an aura that features two or more focal brainstem symptoms. Vertigo is a common aura symptom but never the only aura symptom in MBA. In addition, most patients with MBA develop a migraine headache within 5 to 60 minutes of onset of an aura. Only a small fraction of patients with vestibular migraine meet criteria for MBA [<a href="#rid6">6,7</a>]. (See  <a class="medical medical_review" href="/z/d/html/3352.html" rel="external">"Migraine with brainstem aura"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Brainstem stroke</strong> – Vertigo due to TIA or stroke is frequently accompanied by other symptoms such as dysarthria, diplopia, weakness, or numbness. However, isolated vertigo may be an uncommon presentation of ischemic stroke involving vestibular or cerebellar brainstem pathways [<a href="#rid91">91-96</a>]. Some patients with isolated vestibular symptoms may be found to have other neurologic signs on examination such as limb ataxia, Horner syndrome, or sensory dysfunction. Sudden onset of symptoms and the presence of cerebrovascular risk factors may suggest TIA or stroke as the diagnosis for vestibular symptoms. Hemorrhagic and some ischemic strokes may be identified by head CT; brain MRI is the preferred study to identify acute ischemic infarction. Vascular imaging may help identify stenoses or occlusion as the cause to symptoms for patients with TIA or stroke. (See  <a class="medical medical_review" href="/z/d/html/1102.html" rel="external">"Posterior circulation cerebrovascular syndromes"</a> and  <a class="medical medical_review" href="/z/d/html/1085.html" rel="external">"Neuroimaging of acute stroke"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benign paroxysmal positional vertigo</strong> – Benign paroxysmal positional vertigo (BPPV) is the most common cause of episodic vertigo. BPPV typically presents with recurrent episodes of isolated vertigo that may be similar to vestibular migraine attacks. However, BPPV is often triggered by specific head movements and improves by remaining still. Attacks frequently resolve within one minute, unless head movement triggers another BPPV attack. Migrainous symptoms are not features of BPPV attacks. (See  <a class="medical medical_review" href="/z/d/html/5098.html" rel="external">"Benign paroxysmal positional vertigo"</a>.)</p><p></p><p class="bulletIndent1">BPPV and vestibular migraine can be comorbid, and migraine has been linked to an increased risk of BPPV [<a href="#rid29">29,74,97,98</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Superior semicircular canal dehiscence syndrome</strong> – Superior semicircular canal dehiscence (SSCD) syndrome refers to an abnormal thinning or opening in the bone covering the superior semicircular canal that can allow pressure to move fluid in the semicircular canal and cause vertigo by activating hair cells that sense rotation. Loud sounds can induce pressure waves to trigger a transient sense of vertigo. Vertigo may also be triggered by coughing or Valsalva maneuver. Patients may have pulsatile tinnitus and increased sensitivity to bone-conducted sound with autophony (hearing their own voice as loud or distorted on the affected side) and increased loudness of internal sounds (eg, chewing, eye movements, footsteps). SSCD may be identified by CT of the temporal bone. (See  <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">"Causes of vertigo", section on 'Semicircular canal dehiscence syndrome'</a>.)</p><p></p><p class="bulletIndent1">SSCD and vestibular migraine can be comorbid, as illustrated by a retrospective review of 91 patients with SSCD that identified vestibular migraine in 36 patients (40 percent) [<a href="#rid99">99</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Persistent postural-perceptual dizziness</strong> – Persistent postural-perceptual dizziness (PPPD) refers to a syndrome of chronic functional nonvertiginous dizziness and unsteadiness that combines core features of other previously described distinct syndromes such as phobic postural vertigo and chronic subjective dizziness [<a href="#rid100">100-104</a>]. PPPD typically presents with chronic, fluctuating nonvertiginous dizziness rather than spontaneous vertigo episodes associated with vestibular migraine [<a href="#rid7">7,76</a>].</p><p></p><p class="bulletIndent1">PPPD is often comorbid with vestibular migraine [<a href="#rid105">105</a>]. Whether these symptoms represent a chronic form of vestibular migraine that should be defined separately from comorbid PPPD is uncertain [<a href="#rid66">66,77,105</a>]. However, it is important to distinguish symptoms due to vestibular migraine from the chronic dizziness and unsteadiness due to PPPD, as their management is different.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Episodic ataxia</strong> – Episodic ataxia type 2 (EA2) is a rare genetic disorder involving a pathologic variant in the <em>CACNA1A</em> gene coding for the Ca<sub>v</sub>2.1 pore-forming subunit of the neuronal P/Q-type calcium channel. Patients can present with recurrent disabling episodes of vertigo, nausea/vomiting, ataxia, and nystagmus, often provoked by exertion or emotional stress. Symptoms typically begin in childhood, and brain imaging with MRI may show cerebellar vermis atrophy. <a class="drug drug_general" data-topicid="9268" href="/z/d/drug information/9268.html" rel="external">Acetazolamide</a> may be effective in reducing the frequency of symptoms. (See  <a class="medical medical_review" href="/z/d/html/6234.html" rel="external">"Overview of the hereditary ataxias", section on 'Episodic ataxias'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vestibular paroxysmia</strong> – Vestibular paroxysmia is a term sometimes used to describe very brief (one to several seconds), frequent (up to several times a day) episodes of vertigo without migraine symptoms. It is most commonly attributed to a microvascular compression of the eighth cranial nerve. (See  <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">"Causes of vertigo", section on 'Vestibular paroxysmia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recurrent vestibulopathy</strong> – The entity benign recurrent vertigo refers to spontaneous episodes of vertigo without other migrainous, neurologic, or otologic symptoms or sequelae but has strong links to migraine [<a href="#rid8">8,30,32</a>]. (See  <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">"Causes of vertigo", section on 'Recurrent vestibulopathy'</a>.)</p><p></p><p>The differential diagnosis of vertigo also includes several conditions that present with persistent symptoms or vertigo along with other clinical features  (<a class="graphic graphic_table graphicRef66539" href="/z/d/graphic/66539.html" rel="external">table 3</a>). These disorders are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">"Causes of vertigo"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>The management of vestibular migraine symptoms includes treatment of acute symptoms and prevention of future attacks. Most of the evidence for treatment of vestibular migraine is from case reports and series [<a href="#rid6">6,12,18,53,63,106-111</a>]. The efficacy of treatments for vestibular migraine has not been established in large, well-designed controlled trials [<a href="#rid24">24,112-114</a>]. Current practice recommendations are based on a synthesis of available studies, expert opinion, anecdotal experience, and adaptation from the robust migraine headache literature along with accepted treatments for acute vertigo [<a href="#rid114">114,115</a>].</p><p class="headingAnchor" id="H2907633531"><span class="h2">Indications for treatment</span><span class="headingEndMark"> — </span>Pharmacotherapy for patients with acute vestibular migraine symptoms are typically used for patients with prolonged or severe symptoms. Medications are typically not helpful for episodes that resolve more quickly.</p><p>We suggest preventive treatment for vestibular migraine for patients with episodes that are frequent (three to six per month or more) or if acute treatments are ineffective [<a href="#rid63">63,108</a>]. Indications for prophylactic therapy should mirror those for other forms of migraine headache, which consider the frequency, duration, and disabling nature of the attacks.</p><p class="headingAnchor" id="H3988258131"><span class="h2">Acute treatment</span></p><p class="headingAnchor" id="H4144129313"><span class="h3">Initial therapies</span><span class="headingEndMark"> — </span>For most patients with vestibular migraine with acute symptoms, we suggest initial treatment with vestibular suppressants when the episode is prolonged (eg, more than 30 minutes) or when vertigo or nausea is severe. Options for acute symptoms include:</p><p class="bulletIndent1"><span class="glyph">●</span>Antihistamines (eg, <a class="drug drug_general" data-topicid="9597" href="/z/d/drug information/9597.html" rel="external">meclizine</a>, <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">diphenhydramine</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Antiemetics (eg, <a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">prochlorperazine</a>, <a class="drug drug_general" data-topicid="9820" href="/z/d/drug information/9820.html" rel="external">promethazine</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Benzodiazepines (eg, <a class="drug drug_general" data-topicid="9345" href="/z/d/drug information/9345.html" rel="external">diazepam</a>, <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">lorazepam</a>)</p><p></p><p>The selection of agent is based largely on individual patient symptoms, comorbidities, and risk of adverse effects as studies on acute treatment for patients with vestibular migraine are limited. However, a meta-analysis of 17 clinical trials including 1586 patients that assessed the efficacy of antihistamines and benzodiazepines for acute vertigo found that single-dose antihistamines provided greater acute symptom relief at two hours than single-dose benzodiazepines [<a href="#rid116">116</a>].</p><p>Agents with intravenous or rectal formulations may be preferred if vomiting prevents oral administration  (<a class="graphic graphic_table graphicRef68052" href="/z/d/graphic/68052.html" rel="external">table 4</a>) [<a href="#rid12">12,18</a>]. (See  <a class="medical medical_review" href="/z/d/html/5097.html" rel="external">"Treatment of vertigo", section on 'Symptomatic treatment'</a>.)</p><p class="headingAnchor" id="H1861849307"><span class="h3">Alternative options</span><span class="headingEndMark"> — </span>Triptans may be tried for patients who do not respond to initial acute treatment options and for those who have headache symptoms that accompany vertigo attacks. However, data on the efficacy of triptans for vestibular migraine are limited. In a placebo-controlled trial of 134 patients with vestibular migraine, those who received <a class="drug drug_general" data-topicid="10243" href="/z/d/drug information/10243.html" rel="external">rizatriptan</a> had a similar rate of symptom improvement at one hour as those who received placebo [<a href="#rid117">117</a>]. However, those who received rizatriptan reported improved unsteadiness/dizziness and motion sensitivity at 24 hours and for physical well-being at 48 hours. In a pilot study of <a class="drug drug_general" data-topicid="10233" href="/z/d/drug information/10233.html" rel="external">zolmitriptan</a> for vestibular migraine that enrolled 10 patients treating 17 attacks, there was a numerically higher response rate with treatment versus placebo (38 versus 22 percent) [<a href="#rid107">107</a>]. Low enrollment because of infrequent or brief attacks limited the power of this study.</p><p>Noninvasive vagal nerve stimulation and external trigeminal nerve stimulation have also been reported in single-center retrospective case series as potentially shortening attack duration or reducing vertigo intensity [<a href="#rid118">118,119</a>].</p><p class="headingAnchor" id="H3234345417"><span class="h2">Preventive treatment</span></p><p class="headingAnchor" id="H3562347963"><span class="h3">General measures for all patients</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lifestyle modifications</strong> – Lifestyle modification alone can be effective at reducing dizziness and headaches for some patients [<a href="#rid120">120</a>]. Adequate and restful sleep is an important factor to address and reduce the severity and frequency of episodes. Dietary and environmental triggers should be identified and avoided where possible, although there are limited efficacy data for this approach in vestibular migraine [<a href="#rid12">12,121</a>]. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Precipitating and exacerbating factors'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treat comorbid conditions</strong> – Identifying and treating comorbidities that may mimic or trigger vestibular migraine episodes may help guide appropriate preventive therapies [<a href="#rid76">76</a>]. Common comorbidities include anxiety, benign paroxysmal positional vertigo (BPPV), motion sickness, and persistent postural-perceptual dizziness (PPPD). Meniere disease can be comorbid or confused with vestibular migraine. Such patients warrant careful medical management of both conditions, sometimes using headache symptoms as a marker for treatment response for vestibular migraine. (See  <a class="medical medical_review" href="/z/d/html/5098.html" rel="external">"Benign paroxysmal positional vertigo", section on 'Treatment'</a> and  <a class="medical medical_review" href="/z/d/html/5097.html" rel="external">"Treatment of vertigo"</a> and  <a class="medical medical_review" href="/z/d/html/101879.html" rel="external">"Generalized anxiety disorder in adults: Management"</a> and  <a class="medical medical_review" href="/z/d/html/6859.html" rel="external">"Meniere disease: Evaluation, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1">Patients with vestibular migraine are susceptible to motion sickness. The prevention and treatment of motion sickness is described separately. (See  <a class="medical medical_review" href="/z/d/html/6853.html" rel="external">"Motion sickness"</a>.)</p><p></p><p class="headingAnchor" id="H2199889246"><span class="h3">Prophylactic migraine medications</span><span class="headingEndMark"> — </span>For most patients who take preventive therapy for vestibular migraine, we suggest medications that are effective for migraine prophylaxis. Since high-quality efficacy data are limited in vestibular migraine, and no one therapy has been shown to be superior to another, the choice of medication is driven primarily by the patient's comorbidities and concern for adverse effects. This approach to choosing a prophylactic medication is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/3345.html" rel="external">"Preventive treatment of episodic migraine in adults", section on 'Choosing pharmacologic therapy'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial medication options</strong> – We suggest beta-blockers, antiseizure medications, or antidepressants that are used for prophylaxis for other types of migraine and have been shown to have benefit for vestibular migraine, unless specific medical comorbidities or contraindications exist.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Beta-blockers</strong> – Several beta-blockers may be used for vestibular migraine prevention. We typically use <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">propranolol</a> or <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a>.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">Propranolol</a> extended-release formulation is typically used and started at 60 mg once daily and titrated if needed after two to three weeks to 60 mg twice daily. The dose may be titrated further if needed every two to three weeks by 40 to 80 mg to a typical maximum dose of 120 mg twice daily.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">Metoprolol</a> is started at 50 mg daily and titrated as needed by 50 mg every two to three weeks to a maximum dose of 200 mg daily.</p><p></p><p class="bulletIndent2">Beta-blockers are used with caution in patients with cardiovascular risk factors and those with asthma or depression due to risk of adverse events. (See  <a class="medical medical_review" href="/z/d/html/967.html" rel="external">"Major side effects of beta blockers"</a>.)</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">Propranolol</a> is generally well tolerated and has been associated with reductions in vertigo frequency and severity in uncontrolled before-and-after comparisons and one randomized trial [<a href="#rid122">122-125</a>]. <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">Metoprolol</a> is also commonly used for migraine prophylaxis. A multicenter prevention trial with metoprolol for vestibular migraine failed to show benefit over placebo; however, the trial was terminated due to slow patient accrual after less than 50 percent enrollment [<a href="#rid126">126</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antiseizure medications</strong> – <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">Valproate</a>, <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a>, and <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">lamotrigine</a> are frequently used for migraine prevention. The typical starting, titration, and target dose ranges for these medications are as follows:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">Topiramate</a> is started at 25 mg daily; titrate as needed by up to 25 to 50 mg weekly to 200 mg in two divided doses.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">Valproate</a> is started at 500 mg daily; titrate as needed by 250 to 500 mg weekly up to 1500 mg daily in two divided doses.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">Lamotrigine</a> is started at 25 mg daily; titrate as needed by 50 mg after two weeks, then by 50 mg every one to two weeks thereafter up to a target dose of 200 mg daily in two divided doses.</p><p></p><p class="bulletIndent2">Common adverse effects of <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a> include cognitive impairment, paresthesias, and mood disorders. <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">Valproic acid</a> can commonly cause weight gain or tremors and is <strong>avoided</strong> in females of childbearing age due to risk of teratogenicity. <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">Lamotrigine</a> may cause a cardiac conduction disorder or rash, especially if the dose is titrated rapidly. The adverse effects of these medications are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/2221.html" rel="external">"Antiseizure medications: Mechanism of action, pharmacology, and adverse effects"</a>.)</p><p></p><p class="bulletIndent2">The evidence to support the use of antiseizure medications for vestibular migraine is limited to small trials and open-label studies. <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">Topiramate</a> was found to be associated with a reduction in vertigo and headache frequency and severity in a small unblinded trial, with the lower 25 mg twice-daily dose better tolerated and no less effective than 50 mg twice daily [<a href="#rid127">127</a>]. Other small multiple-arm studies without placebo also reported benefit on vertigo and headache severity with topiramate [<a href="#rid124">124,125,128</a>]. <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">Valproic acid</a> was compared with <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">venlafaxine</a> and <a class="drug drug_general" data-topicid="8869" href="/z/d/drug information/8869.html" rel="external">flunarizine</a> in a small single-blinded randomized trial and found similar reductions in total dizziness handicap inventory (DHI) scores among all three groups and reduced vertigo attack frequency with valproic acid and venlafaxine [<a href="#rid129">129</a>]. <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">Lamotrigine</a> reduced monthly vertigo and headache frequency and was well tolerated in one small retrospective study [<a href="#rid130">130</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antidepressants</strong> – Multiple classes of antidepressant medications may be used for migraine prophylaxis. We prefer <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">venlafaxine</a> or <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">amitriptyline</a> for patients with vestibular migraine.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">Venlafaxine</a> is started at 37.5 mg daily and increased as needed by 37.5 mg weekly up to 150 mg daily.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">Amitriptyline</a> is started at 10 mg at bedtime and increased as needed by 25 mg weekly up to 100 mg at bedtime.</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">Venlafaxine</a> was associated with similar improvements as <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">propranolol</a> in vertigo frequency and severity and overall dizziness handicap but greater improvement in depression measures in an unblinded randomized trial [<a href="#rid122">122</a>]. The venlafaxine group had greater improvement in the emotional domain of the DHI compared with <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">valproic acid</a> and <a class="drug drug_general" data-topicid="8869" href="/z/d/drug information/8869.html" rel="external">flunarizine</a> groups but similar reductions in the vertigo attack frequency and severity in another small single-blinded randomized trial [<a href="#rid129">129</a>]. <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">Amitriptyline</a> and <a class="drug drug_general" data-topicid="9711" href="/z/d/drug information/9711.html" rel="external">nortriptyline</a> have also been reported to be beneficial in small studies [<a href="#rid124">124,125,128</a>].</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">Amitriptyline</a> may cause dry mouth, constipation, orthostatic hypotension, or confusion. <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">Venlafaxine</a> can cause elevation in blood pressure and may worsen headaches in some patients. The adverse effects of these medications are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/1717.html" rel="external">"Tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects", section on 'Amitriptyline'</a> and  <a class="medical medical_review" href="/z/d/html/1713.html" rel="external">"Serotonin-norepinephrine reuptake inhibitors: Pharmacology, administration, and side effects", section on 'Venlafaxine'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alternative options</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Calcium channel blockers</strong> – Several calcium channel blockers are used for migraine prevention. However, there is little evidence to support the use for vestibular migraine.</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="8869" href="/z/d/drug information/8869.html" rel="external">Flunarizine</a>, cinnarizine, and lomerizine have been evaluated for vestibular migraine in several single-treatment and multiple-treatment arm studies. Flunarizine has slightly stronger evidence at reducing vertigo frequency, vertigo severity, DHI, and headache severity [<a href="#rid125">125,129,131,132</a>]. Cinnarizine and lomerizine have less data supporting their reported reductions in headache and vertigo frequency and severity [<a href="#rid133">133-135</a>]. None of these agents are available in the United States.</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="10043" href="/z/d/drug information/10043.html" rel="external">Verapamil</a> is frequently used for other forms of migraine, but the evidence to support the use for vestibular migraine is modest and some studies have failed to find benefit [<a href="#rid111">111,128</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Botulinum toxin</strong> – Botulinum toxin is used for patients with chronic migraine, but the benefit for patients with episodic or vestibular migraine is less certain. In a nonrandomized study of patients with vestibular migraine taking an oral preventive medication, the addition of botulinum toxin A was associated with a greater reduction in headache disability, a reduced vertigo attack frequency, and a similar improvement in dizziness handicap compared with an oral preventive medication alone [<a href="#rid136">136</a>]. A retrospective review of 22 patients with vestibular migraine receiving <a class="drug drug_general" data-topicid="9161" href="/z/d/drug information/9161.html" rel="external">onabotulinumtoxinA</a> reported significant improvements in migraine disability, dizziness handicap, and vertigo attack frequency compared with symptoms prior to treatment [<a href="#rid137">137</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>CGRP antagonists</strong> – Calcitonin gene-related peptide antagonists (CGRP) include agents for acute and preventive treatment of migraine. One small chart review found that anti-CGRP medications were associated with moderate or significant improvement in vestibular and migraine symptoms in 15 of 25 patients [<a href="#rid138">138</a>]. In a prospective observational study of 50 patients with vestibular migraine and symptoms refractory to at least three other preventive medications, use of a CGRP antagonist (<a class="drug drug_general" data-topicid="117927" href="/z/d/drug information/117927.html" rel="external">erenumab</a>, <a class="drug drug_general" data-topicid="119043" href="/z/d/drug information/119043.html" rel="external">fremanezumab</a>, or <a class="drug drug_general" data-topicid="119169" href="/z/d/drug information/119169.html" rel="external">galcanezumab</a>) was associated with a 50 percent or greater reduction in vertigo and headache frequency in 90 and 86 percent, respectively, by 12-month follow-up [<a href="#rid139">139</a>]. Additional data are warranted to better define the role of CGRP antagonists for patients with vestibular migraine [<a href="#rid140">140</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other treatments</strong> – Hormonal treatment for menstrually associated symptoms has been reported to be helpful in isolated cases [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/5441.html" rel="external">"Estrogen-associated migraine headache, including menstrual migraine"</a> and  <a class="medical medical_review" href="/z/d/html/3345.html" rel="external">"Preventive treatment of episodic migraine in adults"</a>.)</p><p></p><p class="headingAnchor" id="H2954432588"><span class="h3">Therapies of uncertain or limited benefit</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vestibular therapy</strong> – Vestibular rehabilitation is frequently used for symptomatic patients with vertigo. However, the benefit of vestibular therapy exercises for patients who have solely unprovoked episodes of vertigo and no chronic dizziness or unsteadiness between attacks has not been established [<a href="#rid141">141</a>]. Studies of vestibular rehabilitation therapy for patients with episodic vestibular migraine have mostly been before-and-after studies without a control group. Most report improvement in a variety of measures, including balance tests, disability measures, vertigo severity, and even headache burden. However, the possibility of confounding conditions such as PPPD is often not reported [<a href="#rid142">142,143</a>].</p><p></p><p class="bulletIndent1">Vestibular therapy may be especially helpful if there are optokinetic or other visual- or self-motion triggers present or if there are forms of chronic nonvertiginous dizziness between episodes of vestibular migraine, in which habituation-type vestibular therapy can be beneficial [<a href="#rid144">144,145</a>]. Therapy exercises are tailored to the patient based on vestibular testing, but may include balance exercises, gaze stability training, and habituation exercises to help desensitize the patient to certain triggers of dizziness. (See  <a class="medical medical_review" href="/z/d/html/5097.html" rel="external">"Treatment of vertigo", section on 'Vestibular rehabilitation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benzodiazepines</strong> – This class of medications has been used as acute vestibular suppressants in patients with vertigo, including vestibular migraine [<a href="#rid12">12,110</a>]. However, we generally limit benzodiazepines to use for acute symptomatic treatment of vertigo, unless such significant anxiety exists that the patient requires a daily benzodiazepine until a better alternative agent can be titrated to a therapeutic dose. (See <a class="local">'Initial therapies'</a> above and  <a class="medical medical_review" href="/z/d/html/5097.html" rel="external">"Treatment of vertigo", section on 'Symptomatic treatment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acetazolamide</strong> – <a class="drug drug_general" data-topicid="9268" href="/z/d/drug information/9268.html" rel="external">Acetazolamide</a> is effective in preventing attacks in episodic ataxia type 2 (EA2) but not widely used in the treatment of either migraine or vertigo. However, two studies have explored its use in vestibular migraine, though poor tolerance and high discontinuation rates were seen [<a href="#rid124">124,146</a>]. (See  <a class="medical medical_review" href="/z/d/html/6234.html" rel="external">"Overview of the hereditary ataxias", section on 'Episodic ataxias'</a>.)</p><p></p><p class="headingAnchor" id="H3539688520"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The natural history of vestibular migraine has not been well studied. In one long-term (median nine years) follow-up of 61 patients with vestibular migraine, 87 percent of patients continued to have recurrent vertigo, although the frequency of episodes was reduced in more than half of patients [<a href="#rid147">147</a>]. Cochlear symptoms (tinnitus, hearing loss) had increased in prevalence from 15 to 49 percent.</p><p class="headingAnchor" id="H3014393189"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110285.html" rel="external">"Society guideline links: Migraine and other primary headache disorders"</a>.)</p><p class="headingAnchor" id="H10131310"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/721.html" rel="external">"Patient education: Vertigo (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Vestibular migraine is a term used to describe episodic vertigo or other vestibular symptoms attributed to migraine. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Vestibular migraine is a common cause of episodic vertigo. As with other forms of migraine, vestibular migraine can affect children as well as adults, and females appear to be more often affected than males. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vertigo</strong> – Vestibular migraine is characterized by recurrent episodes of transient vertigo. Most episodes last minutes to hours and may be spontaneous or triggered by visual or motion stimuli (eg, fluorescent lights, watching trains, busy patterns, crowds). Vertigo can be internal (a false sensation of self-motion) or external (a false sensation that the visual surround is spinning or flowing). (See <a class="local">'Episodic vertigo'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Headache</strong> – Migrainous headaches are associated with most episodes of vestibular migraine. However, vertigo may occur without headache. (See <a class="local">'Migraine headache'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Interictal symptoms</strong> – Patients with vestibular migraine may report a high prevalence of mild vestibular symptoms between attacks. A susceptibility to motion sickness is common. (See <a class="local">'Interictal symptoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of vestibular migraine is made clinically in patients who fulfill diagnostic criteria, after excluding alternative causes of episodic vestibular symptoms. (See <a class="local">'Diagnostic criteria'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – There are no diagnostic tests specific for vestibular migraine. We perform diagnostic testing to exclude alternative causes of episodic vertigo for patients with new-onset symptoms that do not fulfill diagnostic criteria. In addition, diagnostic testing is warranted for those with clinical features that are atypical. (See <a class="local">'Evaluation to exclude alternative conditions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neuroimaging</strong> – We suggest neuroimaging to evaluate for transient ischemic attack (TIA) or stroke when acute vestibular episodes are either new onset, associated with other abnormal neurologic findings on examination, or occur in patients with risk factors for stroke. (See <a class="local">'Neuroimaging'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Audiometry</strong> – We suggest audiometry for patients with prominent or monaural auditory symptoms during episodes and those with symptoms that persist after episodes resolve. (See <a class="local">'Audiometry'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of vestibular migraine includes disorders that produce episodic vertigo  (<a class="graphic graphic_table graphicRef66539" href="/z/d/graphic/66539.html" rel="external">table 3</a>). These most often include Meniere disease, other migraine variants, benign paroxysmal positional vertigo (BPPV), and vertebrobasilar TIAs. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute attacks</strong> – For most patients with disabling symptoms during acute attacks, we suggest a treatment trial with vestibular suppressants rather than triptans at the time of attacks (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Options include antihistamines, antiemetics, or benzodiazepines. Triptans are a reasonable alternative when headache symptoms accompany vertigo attacks or when vertigo acts as a migraine aura. (See <a class="local">'Acute treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preventive treatment</strong> – We suggest preventive treatment for patients with vestibular migraine episodes that are frequent (eg, three to six per month or more) or if acute treatments are ineffective (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). For most patients, we prefer beta-blockers, antiseizure medications, or antidepressants rather than other medications used for migraine prophylaxis, unless specific medical comorbidities or contraindications exist. Options include (see <a class="local">'Prophylactic migraine medications'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">Propranolol</a> or <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">Topiramate</a>, <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">valproate</a>, or <a class="drug drug_general" data-topicid="9545" href="/z/d/drug information/9545.html" rel="external">lamotrigine</a></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">Venlafaxine</a> or <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">amitriptyline</a></p><p></p><p class="headingAnchor" id="H483597956"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges David F Black, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lempert T, Olesen J, Furman J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res 2012; 22:167.</a></li><li><a class="nounderline abstract_t">Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.</a></li><li><a class="nounderline abstract_t">BASSER LS. BENIGN PAROXYSMAL VERTIGO OF CHILDHOOD. (A VARIETY OF VESTIBULAR NEURONITIS). Brain 1964; 87:141.</a></li><li><a class="nounderline abstract_t">Fenichel GM. Migraine as a cause of benign paroxysmal vertigo of childhood. J Pediatr 1967; 71:114.</a></li><li><a class="nounderline abstract_t">van de Berg R, Widdershoven J, Bisdorff A, et al. Vestibular Migraine of Childhood and Recurrent Vertigo of Childhood: Diagnostic criteria Consensus document of the Committee for the Classification of Vestibular Disorders of the Bárány Society and the International Headache Society. J Vestib Res 2021; 31:1.</a></li><li><a class="nounderline abstract_t">Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 1999; 246:883.</a></li><li><a class="nounderline abstract_t">Eggers SD, Staab JP, Neff BA, et al. Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities. Otol Neurotol 2011; 32:1144.</a></li><li><a class="nounderline abstract_t">Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain 1984; 107 ( Pt 4):1123.</a></li><li><a class="nounderline abstract_t">Sturzenegger MH, Meienberg O. Basilar artery migraine: a follow-up study of 82 cases. Headache 1985; 25:408.</a></li><li><a class="nounderline abstract_t">Olsson JE. Neurotologic findings in basilar migraine. Laryngoscope 1991; 101:1.</a></li><li class="breakAll">Liveing E. On Megrim, Sick-Headache, and Some Allied Disorders, Churchill, London 1873.</li><li><a class="nounderline abstract_t">Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998; 108:1.</a></li><li><a class="nounderline abstract_t">SELBY G, LANCE JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960; 23:23.</a></li><li><a class="nounderline abstract_t">Kuritzky A, Ziegler DK, Hassanein R. Vertigo, motion sickness and migraine. Headache 1981; 21:227.</a></li><li><a class="nounderline abstract_t">Bayazit Y, Yilmaz M, Mumbuç S, Kanlikama M. Assessment of migraine-related cochleovestibular symptoms. Rev Laryngol Otol Rhinol (Bord) 2001; 122:85.</a></li><li><a class="nounderline abstract_t">Neuhauser HK, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005; 65:898.</a></li><li><a class="nounderline abstract_t">Ishizaki K, Mori N, Takeshima T, et al. Static stabilometry in patients with migraine and tension-type headache during a headache-free period. Psychiatry Clin Neurosci 2002; 56:85.</a></li><li><a class="nounderline abstract_t">Baloh RW. Neurotology of migraine. Headache 1997; 37:615.</a></li><li><a class="nounderline abstract_t">Golding JF. Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 1998; 47:507.</a></li><li><a class="nounderline abstract_t">Aromaa M, Sillanpää ML, Rautava P, Helenius H. Childhood headache at school entry: a controlled clinical study. Neurology 1998; 50:1729.</a></li><li><a class="nounderline abstract_t">Murdin L, Chamberlain F, Cheema S, et al. Motion sickness in migraine and vestibular disorders. J Neurol Neurosurg Psychiatry 2015; 86:585.</a></li><li><a class="nounderline abstract_t">Drummond PD. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalalgia 2002; 22:117.</a></li><li><a class="nounderline abstract_t">Drummond PD. Triggers of motion sickness in migraine sufferers. Headache 2005; 45:653.</a></li><li><a class="nounderline abstract_t">Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol 2013; 12:706.</a></li><li><a class="nounderline abstract_t">Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 2003; 16:5.</a></li><li><a class="nounderline abstract_t">Celebisoy N, Gökçay F, Sirin H, Biçak N. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia 2008; 28:72.</a></li><li><a class="nounderline abstract_t">Teggi R, Colombo B, Bernasconi L, et al. Migrainous vertigo: results of caloric testing and stabilometric findings. Headache 2009; 49:435.</a></li><li><a class="nounderline abstract_t">Baier B, Stieber N, Dieterich M. Vestibular-evoked myogenic potentials in vestibular migraine. J Neurol 2009; 256:1447.</a></li><li><a class="nounderline abstract_t">Neuhauser H, Leopold M, von Brevern M, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001; 56:436.</a></li><li><a class="nounderline abstract_t">Cha YH, Lee H, Santell LS, Baloh RW. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia 2009; 29:550.</a></li><li><a class="nounderline abstract_t">Lee H, Sohn SI, Jung DK, et al. Migraine and isolated recurrent vertigo of unknown cause. Neurol Res 2002; 24:663.</a></li><li><a class="nounderline abstract_t">Oh AK, Lee H, Jen JC, et al. Familial benign recurrent vertigo. Am J Med Genet 2001; 100:287.</a></li><li><a class="nounderline abstract_t">Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psychiatry 1979; 42:363.</a></li><li><a class="nounderline abstract_t">Moretti G, Manzoni GC, Caffarra P, Parma M. "Benign recurrent vertigo" and its connection with migraine. Headache 1980; 20:344.</a></li><li><a class="nounderline abstract_t">Lanzi G, Balottin U, Fazzi E, et al. Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia 1994; 14:458.</a></li><li><a class="nounderline abstract_t">Neuhauser HK, Radtke A, von Brevern M, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology 2006; 67:1028.</a></li><li><a class="nounderline abstract_t">Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache 1992; 32:300.</a></li><li><a class="nounderline abstract_t">Seemungal B, Rudge P, Davies R, et al. Three patients with migraine following caloric-induced vestibular stimulation. J Neurol 2006; 253:1000.</a></li><li><a class="nounderline abstract_t">Murdin L, Davies RA, Bronstein AM. Vertigo as a migraine trigger. Neurology 2009; 73:638.</a></li><li><a class="nounderline abstract_t">Zhang Y, Zhang Y, Tian K, et al. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine. J Headache Pain 2020; 21:72.</a></li><li><a class="nounderline abstract_t">Tian R, Zhang Y, Pan Q, et al. Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model. J Headache Pain 2022; 23:35.</a></li><li><a class="nounderline abstract_t">Marano E, Marcelli V, Di Stasio E, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache 2005; 45:325.</a></li><li><a class="nounderline abstract_t">Harno H, Hirvonen T, Kaunisto MA, et al. Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology 2003; 61:1748.</a></li><li><a class="nounderline abstract_t">King S, Wang J, Priesol AJ, Lewis RF. Central Integration of Canal and Otolith Signals is Abnormal in Vestibular Migraine. Front Neurol 2014; 5:233.</a></li><li><a class="nounderline abstract_t">Lewis RF, Priesol AJ, Nicoucar K, et al. Dynamic tilt thresholds are reduced in vestibular migraine. J Vestib Res 2011; 21:323.</a></li><li><a class="nounderline abstract_t">Winnick A, Sadeghpour S, Otero-Millan J, et al. Errors of Upright Perception in Patients With Vestibular Migraine. Front Neurol 2018; 9:892.</a></li><li><a class="nounderline abstract_t">Krishnan PS, Carey JP. Vestibular Migraine: Clinical Aspects and Pathophysiology. Otolaryngol Clin North Am 2022; 55:531.</a></li><li><a class="nounderline abstract_t">Chen Z, Xiao L, Liu H, et al. Altered thalamo-cortical functional connectivity in patients with vestibular migraine: a resting-state fMRI study. Neuroradiology 2022; 64:119.</a></li><li><a class="nounderline abstract_t">Zhe X, Chen L, Zhang D, et al. Cortical Areas Associated With Multisensory Integration Showing Altered Morphology and Functional Connectivity in Relation to Reduced Life Quality in Vestibular Migraine. Front Hum Neurosci 2021; 15:717130.</a></li><li><a class="nounderline abstract_t">Baloh RW, Yue Q, Furman JM, Nelson SF. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 1997; 41:8.</a></li><li><a class="nounderline abstract_t">Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology 2004; 62:17.</a></li><li><a class="nounderline abstract_t">Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87:543.</a></li><li><a class="nounderline abstract_t">Baloh RW, Foster CA, Yue Q, Nelson SF. Familial migraine with vertigo and essential tremor. Neurology 1996; 46:458.</a></li><li><a class="nounderline abstract_t">Baloh RW, Jacobson K, Fife T. Familial vestibulopathy: a new dominantly inherited syndrome. Neurology 1994; 44:20.</a></li><li><a class="nounderline abstract_t">Oh EH, Shin JH, Cho JW, et al. TRPM7 as a Candidate Gene for Vestibular Migraine. Front Neurol 2020; 11:595042.</a></li><li><a class="nounderline abstract_t">Radtke A, Lempert T, Gresty MA, et al. Migraine and Ménière's disease: is there a link? Neurology 2002; 59:1700.</a></li><li><a class="nounderline abstract_t">Lee H, Lopez I, Ishiyama A, Baloh RW. Can migraine damage the inner ear? Arch Neurol 2000; 57:1631.</a></li><li><a class="nounderline abstract_t">Neff BA, Staab JP, Eggers SD, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière's disease, vestibular migraine, and Ménière's disease with concomitant vestibular migraine. Otol Neurotol 2012; 33:1235.</a></li><li><a class="nounderline abstract_t">Li M, Xu X, Qi W, et al. Vestibular migraine: the chameleon in vestibular disease. Neurol Sci 2021; 42:1719.</a></li><li><a class="nounderline abstract_t">Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The Epidemiology of Vestibular Migraine: A Population-based Survey Study. Otol Neurotol 2018; 39:1037.</a></li><li><a class="nounderline abstract_t">von Brevern M, Neuhauser H. Epidemiological evidence for a link between vertigo and migraine. J Vestib Res 2011; 21:299.</a></li><li><a class="nounderline abstract_t">Baloh RW. Vestibular Migraine I: Mechanisms, Diagnosis, and Clinical Features. Semin Neurol 2020; 40:76.</a></li><li><a class="nounderline abstract_t">Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 2002; 23:364.</a></li><li><a class="nounderline abstract_t">Li ZY, Shen B, Si LH, et al. Clinical characteristics of definite vestibular migraine diagnosed according to criteria jointly formulated by the Bárány Society and the International Headache Society. Braz J Otorhinolaryngol 2022; 88 Suppl 3:S147.</a></li><li><a class="nounderline abstract_t">Thakar A, Anjaneyulu C, Deka RC. Vertigo syndromes and mechanisms in migraine. J Laryngol Otol 2001; 115:782.</a></li><li><a class="nounderline abstract_t">Beh SC, Masrour S, Smith SV, Friedman DI. The Spectrum of Vestibular Migraine: Clinical Features, Triggers, and Examination Findings. Headache 2019; 59:727.</a></li><li><a class="nounderline abstract_t">Lempert T, Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine. J Neurol 2009; 256:333.</a></li><li><a class="nounderline abstract_t">Cohen JM, Bigal ME, Newman LC. Migraine and vestibular symptoms--identifying clinical features that predict "vestibular migraine". Headache 2011; 51:1393.</a></li><li><a class="nounderline abstract_t">Huang TC, Wang SJ, Kheradmand A. Vestibular migraine: An update on current understanding and future directions. Cephalalgia 2020; 40:107.</a></li><li><a class="nounderline abstract_t">Radtke A, Neuhauser H, von Brevern M, et al. Vestibular migraine--validity of clinical diagnostic criteria. Cephalalgia 2011; 31:906.</a></li><li><a class="nounderline abstract_t">Brantberg K, Trees N, Baloh RW. Migraine-associated vertigo. Acta Otolaryngol 2005; 125:276.</a></li><li><a class="nounderline abstract_t">Wang CT, Lai MS, Young YH. Relationship between basilar-type migraine and migrainous vertigo. Headache 2009; 49:426.</a></li><li><a class="nounderline abstract_t">Salhofer S, Lieba-Samal D, Freydl E, et al. Migraine and vertigo--a prospective diary study. Cephalalgia 2010; 30:821.</a></li><li><a class="nounderline abstract_t">von Brevern M, Radtke A, Clarke AH, Lempert T. Migrainous vertigo presenting as episodic positional vertigo. Neurology 2004; 62:469.</a></li><li><a class="nounderline abstract_t">Lempert T, von Brevern M. Vestibular Migraine. Neurol Clin 2019; 37:695.</a></li><li><a class="nounderline abstract_t">Eggers SD, Neff BA, Shepard NT, Staab JP. Comorbidities in vestibular migraine. J Vestib Res 2014; 24:387.</a></li><li><a class="nounderline abstract_t">Chae R, Krauter R, Pasquesi LL, Sharon JD. Broadening vestibular migraine diagnostic criteria: A prospective cohort study on vestibular migraine subtypes. J Vestib Res 2022; 32:453.</a></li><li><a class="nounderline abstract_t">Boldingh MI, Ljøstad U, Mygland A, Monstad P. Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility. Cephalalgia 2011; 31:1211.</a></li><li><a class="nounderline abstract_t">Jeong SH, Oh SY, Kim HJ, et al. Vestibular dysfunction in migraine: effects of associated vertigo and motion sickness. J Neurol 2010; 257:905.</a></li><li><a class="nounderline abstract_t">Eckhardt-Henn A, Best C, Bense S, et al. Psychiatric comorbidity in different organic vertigo syndromes. J Neurol 2008; 255:420.</a></li><li><a class="nounderline abstract_t">Furman JM, Balaban CD, Jacob RG, Marcus DA. Migraine-anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry 2005; 76:1.</a></li><li><a class="nounderline abstract_t">Best C, Eckhardt-Henn A, Tschan R, Dieterich M. Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year. J Neurol 2009; 256:58.</a></li><li><a class="nounderline abstract_t">Best C, Tschan R, Eckhardt-Henn A, Dieterich M. Who is at risk for ongoing dizziness and psychological strain after a vestibular disorder? Neuroscience 2009; 164:1579.</a></li><li><a class="nounderline abstract_t">von Brevern M, Zeise D, Neuhauser H, et al. Acute migrainous vertigo: clinical and oculographic findings. Brain 2005; 128:365.</a></li><li><a class="nounderline abstract_t">Young AS, Nham B, Bradshaw AP, et al. Clinical, oculographic, and vestibular test characteristics of vestibular migraine. Cephalalgia 2021; 41:1039.</a></li><li><a class="nounderline abstract_t">Thomas JO, Sharobeam A, Venkat A, et al. Video head impulse testing to differentiate vestibular neuritis from posterior circulation stroke in the emergency department: a prospective observational study. BMJ Neurol Open 2022; 4:e000284.</a></li><li><a class="nounderline abstract_t">Newman-Toker DE, Sharma P, Chowdhury M, et al. Penlight-cover test: a new bedside method to unmask nystagmus. J Neurol Neurosurg Psychiatry 2009; 80:900.</a></li><li><a class="nounderline abstract_t">Young AS, Lechner C, Bradshaw AP, et al. Capturing acute vertigo: A vestibular event monitor. Neurology 2019; 92:e2743.</a></li><li><a class="nounderline abstract_t">Lempert T, Olesen J, Furman J, et al. Vestibular migraine: Diagnostic criteria1. J Vestib Res 2022; 32:1.</a></li><li><a class="nounderline abstract_t">Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Menière's disease. J Vestib Res 2015; 25:1.</a></li><li><a class="nounderline abstract_t">Kim JS. Vertigo and gait ataxia without usual signs of lateral medullary infarction: a clinical variant related to rostral-dorsolateral lesions. Cerebrovasc Dis 2000; 10:471.</a></li><li><a class="nounderline abstract_t">Kim SH, Kim HJ, Kim JS. Isolated vestibular syndromes due to brainstem and cerebellar lesions. J Neurol 2017; 264:63.</a></li><li><a class="nounderline abstract_t">Choi JH, Kim HW, Choi KD, et al. Isolated vestibular syndrome in posterior circulation stroke: Frequency and involved structures. Neurol Clin Pract 2014; 4:410.</a></li><li><a class="nounderline abstract_t">Lee H, Sohn SI, Cho YW, et al. Cerebellar infarction presenting isolated vertigo: frequency and vascular topographical patterns. Neurology 2006; 67:1178.</a></li><li><a class="nounderline abstract_t">Paul NL, Simoni M, Rothwell PM, Oxford Vascular Study. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol 2013; 12:65.</a></li><li><a class="nounderline abstract_t">Kattah JC, Talkad AV, Wang DZ, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 2009; 40:3504.</a></li><li><a class="nounderline abstract_t">Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol 2000; 109:377.</a></li><li><a class="nounderline abstract_t">Lempert T, Leopold M, von Brevern M, Neuhauser H. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol 2000; 109:1176.</a></li><li><a class="nounderline abstract_t">Smetak MR, Cass ND, Manzoor NF, et al. Vestibular Migraine Confounds Management of Superior Canal Dehiscence Syndrome. Otol Neurotol 2022; 43:835.</a></li><li><a class="nounderline abstract_t">Dieterich M, Staab JP. Functional dizziness: from phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness. Curr Opin Neurol 2017; 30:107.</a></li><li><a class="nounderline abstract_t">Brandt T. Phobic postural vertigo. Neurology 1996; 46:1515.</a></li><li><a class="nounderline abstract_t">Staab JP, Ruckenstein MJ. Which comes first? Psychogenic dizziness versus otogenic anxiety. Laryngoscope 2003; 113:1714.</a></li><li><a class="nounderline abstract_t">Staab JP, Ruckenstein MJ. Expanding the differential diagnosis of chronic dizziness. Arch Otolaryngol Head Neck Surg 2007; 133:170.</a></li><li><a class="nounderline abstract_t">Staab JP, Eckhardt-Henn A, Horii A, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res 2017; 27:191.</a></li><li><a class="nounderline abstract_t">Azzi JL, Khoury M, Séguin J, et al. Characteristics of persistent postural perceptual dizziness patients in a multidisciplinary dizziness clinic. J Vestib Res 2022; 32:285.</a></li><li><a class="nounderline abstract_t">Evans RW, Baloh RW. Episodic vertigo and migraine. Headache 2001; 41:604.</a></li><li><a class="nounderline abstract_t">Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 2003; 60:882.</a></li><li><a class="nounderline abstract_t">Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997; 18:350.</a></li><li><a class="nounderline abstract_t">Baier B, Winkenwerder E, Dieterich M. "Vestibular migraine": effects of prophylactic therapy with various drugs. A retrospective study. J Neurol 2009; 256:436.</a></li><li><a class="nounderline abstract_t">Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 2006; 116:1782.</a></li><li><a class="nounderline abstract_t">Fotuhi M, Glaun B, Quan SY, Sofare T. Vestibular migraine: a critical review of treatment trials. J Neurol 2009; 256:711.</a></li><li><a class="nounderline abstract_t">Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia 2004; 24:83.</a></li><li><a class="nounderline abstract_t">Maldonado Fernández M, Birdi JS, Irving GJ, et al. Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev 2015; :CD010600.</a></li><li><a class="nounderline abstract_t">Byun YJ, Levy DA, Nguyen SA, et al. Treatment of Vestibular Migraine: A Systematic Review and Meta-analysis. Laryngoscope 2021; 131:186.</a></li><li><a class="nounderline abstract_t">Smyth D, Britton Z, Murdin L, et al. Vestibular migraine treatment: a comprehensive practical review. Brain 2022; 145:3741.</a></li><li><a class="nounderline abstract_t">Hunter BR, Wang AZ, Bucca AW, et al. Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo: A Systematic Review and Meta-analysis. JAMA Neurol 2022; 79:846.</a></li><li class="breakAll">Baloh RW. Rizatriptan for Episodic Dizziness in Vestibular Migraine. https://clinicaltrials.gov/ct2/show/study/NCT02447991. (Accessed on August 12, 2022).</li><li><a class="nounderline abstract_t">Beh SC. External trigeminal nerve stimulation: Potential rescue treatment for acute vestibular migraine. J Neurol Sci 2020; 408:116550.</a></li><li><a class="nounderline abstract_t">Beh SC, Friedman DI. Acute vestibular migraine treatment with noninvasive vagus nerve stimulation. Neurology 2019; 93:e1715.</a></li><li><a class="nounderline abstract_t">Roberts RA, Watford KE, Picou EM, et al. Effects of Lifestyle Modification on Vestibular Migraine. Otol Neurotol 2021; 42:e1537.</a></li><li><a class="nounderline abstract_t">Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol 2012; 33:121.</a></li><li><a class="nounderline abstract_t">Salviz M, Yuce T, Acar H, et al. Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial. Laryngoscope 2016; 126:169.</a></li><li><a class="nounderline abstract_t">Çelik O, Tanyeri Toker G, Eskiizmir G, et al. The Effectiveness of Medical Prophylactic Treatment on Vestibular Migraine and Its Effect on the Quality Of Life. J Int Adv Otol 2020; 16:28.</a></li><li><a class="nounderline abstract_t">Domínguez-Durán E, Montilla-Ibáñez MA, Álvarez-Morujo de Sande MG, et al. Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug. Eur Arch Otorhinolaryngol 2020; 277:1013.</a></li><li><a class="nounderline abstract_t">Salmito MC, Duarte JA, Morganti LOG, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol 2017; 83:404.</a></li><li><a class="nounderline abstract_t">Bayer O, Adrion C, Al Tawil A, et al. Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG). Trials 2019; 20:813.</a></li><li><a class="nounderline abstract_t">Gode S, Celebisoy N, Kirazli T, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache 2010; 50:77.</a></li><li><a class="nounderline abstract_t">Dornhoffer JR, Liu YF, Donaldson L, Rizk HG. Factors implicated in response to treatment/prognosis of vestibular migraine. Eur Arch Otorhinolaryngol 2021; 278:57.</a></li><li><a class="nounderline abstract_t">Liu F, Ma T, Che X, et al. The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine. Front Neurol 2017; 8:524.</a></li><li><a class="nounderline abstract_t">Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb 2004; :103.</a></li><li><a class="nounderline abstract_t">Lepcha A, Amalanathan S, Augustine AM, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol 2014; 271:2931.</a></li><li><a class="nounderline abstract_t">Rashid SMU, Sumaria S, Koohi N, et al. Patient Experience of Flunarizine for Vestibular Migraine: Single Centre Observational Study. Brain Sci 2022; 12.</a></li><li><a class="nounderline abstract_t">Iwasaki S, Ushio M, Chihara Y, et al. Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. Acta Otolaryngol Suppl 2007; :45.</a></li><li><a class="nounderline abstract_t">Taghdiri F, Togha M, Razeghi Jahromi S, Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus 2014; 3:231.</a></li><li><a class="nounderline abstract_t">Teggi R, Colombo B, Gatti O, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci 2015; 36:1869.</a></li><li><a class="nounderline abstract_t">Görür K, Gür H, İsmi O, et al. The effectiveness of propranolol, flunarizine, amitriptyline and botulinum toxin in vestibular migraine complaints and prophylaxis: a non-randomized controlled study. Braz J Otorhinolaryngol 2022; 88:975.</a></li><li><a class="nounderline abstract_t">Surmeli RH, Habeşoğlu TE. A New Treatment Option for Vestibular Migraine: Onabotulinum Toxin Type A. Istanbul Medical Journal 2020; 21:177.</a></li><li><a class="nounderline abstract_t">Hoskin JL, Fife TD. New Anti-CGRP Medications in the Treatment of Vestibular Migraine. Front Neurol 2021; 12:799002.</a></li><li><a class="nounderline abstract_t">Russo CV, Saccà F, Braca S, et al. Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study. Cephalalgia 2023; 43:3331024231161809.</a></li><li class="breakAll">University of California, San Francisco. Galcanezumab for Vestibular Migraine https://clinicaltrials.gov/ct2/show/NCT04417361 (Accessed on August 12, 2022).</li><li><a class="nounderline abstract_t">Alghadir AH, Anwer S. Effects of Vestibular Rehabilitation in the Management of a Vestibular Migraine: A Review. Front Neurol 2018; 9:440.</a></li><li><a class="nounderline abstract_t">Balci B, Akdal G. Outcome of vestibular rehabilitation in vestibular migraine. J Neurol 2022; 269:6246.</a></li><li><a class="nounderline abstract_t">Graham MK, Staab JP, Lohse CM, McCaslin DL. A Comparison of Dizziness Handicap Inventory Scores by Categories of Vestibular Diagnoses. Otol Neurotol 2021; 42:129.</a></li><li><a class="nounderline abstract_t">Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope 2000; 110:1528.</a></li><li><a class="nounderline abstract_t">Thompson KJ, Goetting JC, Staab JP, Shepard NT. Retrospective review and telephone follow-up to evaluate a physical therapy protocol for treating persistent postural-perceptual dizziness: A pilot study. J Vestib Res 2015; 25:97.</a></li><li><a class="nounderline abstract_t">Çelebisoy N, Gökçay F, Karahan C, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol 2016; 273:2947.</a></li><li><a class="nounderline abstract_t">Radtke A, von Brevern M, Neuhauser H, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology 2012; 79:1607.</a></li></ol></div><div id="topicVersionRevision">Topic 3356 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23142830" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Vestibular migraine: diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14152207" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : BENIGN PAROXYSMAL VERTIGO OF CHILDHOOD. (A VARIETY OF VESTIBULAR NEURONITIS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5293847" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Migraine as a cause of benign paroxysmal vertigo of childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33386837" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Vestibular Migraine of Childhood and Recurrent Vertigo of Childhood: Diagnostic criteria Consensus document of the Committee for the Classification of Vestibular Disorders of the Bárány Society and the International Headache Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10552234" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Episodic vertigo related to migraine (90 cases): vestibular migraine?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21799457" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6334543" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Neuro-otological manifestations of migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4086291" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Basilar artery migraine: a follow-up study of 82 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984561" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Neurotologic findings in basilar migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984561" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Neurotologic findings in basilar migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9430502" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Medical management of migraine-related dizziness and vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14444681" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Observations on 500 cases of migraine and allied vascular headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7287423" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Vertigo, motion sickness and migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11715266" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Assessment of migraine-related cochleovestibular symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16186531" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Epidemiology of vestibular vertigo: a neurotologic survey of the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11929575" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Static stabilometry in patients with migraine and tension-type headache during a headache-free period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9439080" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Neurotology of migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10052582" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9633718" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Childhood headache at school entry: a controlled clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25118205" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Motion sickness in migraine and vestibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11972579" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15953297" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Triggers of motion sickness in migraine sufferers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23769597" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Vestibular migraine: clinical aspects and pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12544852" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17999681" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Migrainous vertigo: clinical, oculographic and posturographic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19220504" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Migrainous vertigo: results of caloric testing and stabilometric findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19377861" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Vestibular-evoked myogenic potentials in vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11222783" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The interrelations of migraine, vertigo, and migrainous vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19170697" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Association of benign recurrent vertigo and migraine in 208 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12392202" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Migraine and isolated recurrent vertigo of unknown cause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11343320" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Familial benign recurrent vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/458483" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Benign recurrent vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7216756" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : "Benign recurrent vertigo" and its connection with migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7697708" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Benign paroxysmal vertigo of childhood: a long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17000973" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Migrainous vertigo: prevalence and impact on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1399552" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Migraine-associated dizziness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16607475" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Three patients with migraine following caloric-induced vestibular stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19704084" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Vertigo as a migraine trigger.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32522232" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35260079" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15836568" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14694041" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Subclinical vestibulocerebellar dysfunction in migraine with and without aura.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25426098" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Central Integration of Canal and Otolith Signals is Abnormal in Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22348937" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Dynamic tilt thresholds are reduced in vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30425678" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Errors of Upright Perception in Patients With Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35477842" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Vestibular Migraine: Clinical Aspects and Pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34374821" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Altered thalamo-cortical functional connectivity in patients with vestibular migraine: a resting-state fMRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34483869" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Cortical Areas Associated With Multisensory Integration Showing Altered Morphology and Functional Connectivity in Relation to Reduced Life Quality in Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9005860" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14718690" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Clinical spectrum of episodic ataxia type 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8898206" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8614512" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Familial migraine with vertigo and essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8290084" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Familial vestibulopathy: a new dominantly inherited syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33193064" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : TRPM7 as a Candidate Gene for Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12473755" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Migraine and Ménière's disease: is there a link?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11074796" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Can migraine damage the inner ear?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22801040" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière's disease, vestibular migraine, and Ménière's disease with concomitant vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33666767" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Vestibular migraine: the chameleon in vestibular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30020261" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The Epidemiology of Vestibular Migraine: A Population-based Survey Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22348934" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Epidemiological evidence for a link between vertigo and migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31935766" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Vestibular Migraine I: Mechanisms, Diagnosis, and Clinical Features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11981397" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Migraine-associated dizziness: patient characteristics and management options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35177357" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Clinical characteristics of definite vestibular migraine diagnosed according to criteria jointly formulated by the Bárány Society and the International Headache Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11667987" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Vertigo syndromes and mechanisms in migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30737783" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The Spectrum of Vestibular Migraine: Clinical Features, Triggers, and Examination Findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19225823" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Epidemiology of vertigo, migraine and vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21649658" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Migraine and vestibular symptoms--identifying clinical features that predict "vestibular migraine".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31394919" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Vestibular migraine: An update on current understanding and future directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21508087" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Vestibular migraine--validity of clinical diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15966697" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Migraine-associated vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19178580" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Relationship between basilar-type migraine and migrainous vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20647173" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Migraine and vertigo--a prospective diary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14872034" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Migrainous vertigo presenting as episodic positional vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31563227" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25564081" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Comorbidities in vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35124629" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Broadening vestibular migraine diagnostic criteria: A prospective cohort study on vestibular migraine subtypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21768183" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20041331" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Vestibular dysfunction in migraine: effects of associated vertigo and motion sickness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18338198" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Psychiatric comorbidity in different organic vertigo syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15607984" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Migraine-anxiety related dizziness (MARD): a new disorder?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19221849" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19828125" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Who is at risk for ongoing dizziness and psychological strain after a vestibular disorder?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15601663" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Acute migrainous vertigo: clinical and oculographic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33938251" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Clinical, oculographic, and vestibular test characteristics of vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35571585" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Video head impulse testing to differentiate vestibular neuritis from posterior circulation stroke in the emergency department: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19336432" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Penlight-cover test: a new bedside method to unmask nystagmus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31092626" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Capturing acute vertigo: A vestibular event monitor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34719447" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Vestibular migraine: Diagnostic criteria1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25882471" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Diagnostic criteria for Menière's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11070379" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Vertigo and gait ataxia without usual signs of lateral medullary infarction: a clinical variant related to rostral-dorsolateral lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28314977" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Isolated vestibular syndromes due to brainstem and cerebellar lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29443249" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Isolated vestibular syndrome in posterior circulation stroke: Frequency and involved structures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17030749" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Cerebellar infarction presenting isolated vertigo: frequency and vascular topographical patterns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23206553" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19762709" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10778892" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Migraine and benign positional vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11130835" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Migraine and benign positional vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35878641" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Vestibular Migraine Confounds Management of Superior Canal Dehiscence Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28002123" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Functional dizziness: from phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8649539" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Phobic postural vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14520095" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Which comes first? Psychogenic dizziness versus otogenic anxiety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17309987" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Expanding the differential diagnosis of chronic dizziness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29036855" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34151875" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Characteristics of persistent postural perceptual dizziness patients in a multidisciplinary dizziness clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11437901" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Episodic vertigo and migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12629256" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9149830" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19266150" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : "Vestibular migraine": effects of prophylactic therapy with various drugs. A retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17003732" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Migraine-related vertigo: diagnostic criteria and prophylactic treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19252785" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Vestibular migraine: a critical review of treatment trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14728703" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Vertigo and dizziness related to migraine: a diagnostic challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26093662" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Pharmacological agents for the prevention of vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32083732" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Treatment of Vestibular Migraine: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35859353" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Vestibular migraine treatment: a comprehensive practical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35849408" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35849408" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31677559" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : External trigeminal nerve stimulation: Potential rescue treatment for acute vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31554650" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Acute vestibular migraine treatment with noninvasive vagus nerve stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34325453" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Effects of Lifestyle Modification on Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21704423" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26228645" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31347507" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : The Effectiveness of Medical Prophylactic Treatment on Vestibular Migraine and Its Effect on the Quality Of Life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32008074" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27320656" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Prophylactic treatment of vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31888723" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19656221" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Clinical assessment of topiramate therapy in patients with migrainous vertigo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32449023" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Factors implicated in response to treatment/prognosis of vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29075232" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15641316" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Treatment of migraine related vertigo with lamotrigine an observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24166742" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35447947" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Patient Experience of Flunarizine for Vestibular Migraine: Single Centre Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18340570" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24834377" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26037548" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33722518" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : The effectiveness of propranolol, flunarizine, amitriptyline and botulinum toxin in vestibular migraine complaints and prophylaxis: a non-randomized controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : A New Treatment Option for Vestibular Migraine: Onabotulinum Toxin Type A</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35153979" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : New Anti-CGRP Medications in the Treatment of Vestibular Migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36946234" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36946234" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29946294" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Effects of Vestibular Rehabilitation in the Management of a Vestibular Migraine: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35802200" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Outcome of vestibular rehabilitation in vestibular migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33229883" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : A Comparison of Dizziness Handicap Inventory Scores by Categories of Vestibular Diagnoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10983955" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26410674" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Retrospective review and telephone follow-up to evaluate a physical therapy protocol for treating persistent postural-perceptual dizziness: A pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26728486" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Acetazolamide in vestibular migraine prophylaxis: a retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23019266" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
